ArticleNucleic acids research2026
mRNA cap formation by the human respiratory syncytial virus large protein.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The mechanisms underlying mRNA capping in non-segmented negative-strand RNA viruses, except rhabdoviruses, remain elusive. Here, we demonstrate that the RNA-dependent RNA polymerase (RdRp), composed of the large protein (L) and the phosphoprotein (P), of human respiratory syncytial virus (HRSV, a pneumovirus) catalyzes capping through GDP polyribonucleotidyltransferase (PRNTase) activity, which transfers 5'-monophosphorylated RNA (pRNA) from 5'-triphosphorylated RNA to GDP via a putative covalent L-pRNA intermediate. The HR motif (motif D) on the catalytic loop of the L PRNTase domain is critical for capping, whereas the GxxT sequence in motif B is dispensable, unlike in rhabdoviruses. The capping activity is inhibited at the intermediate formation step by JNJ-8003, an antiviral compound that binds a cleft between motifs D and E. Pneumovirus-specific residues in the HRSV counterpart of the rhabdovirus priming-capping loop are not essential for either capping or de novo RNA synthesis initiation, although a di-lysine sequence is required for efficient capping. The L-P complex preferentially methylates the cap core at the guanine-N7 position and then methylates cap 0 at the 2'-O position, forming cap 1, in direct contrast to the methylation order observed in rhabdoviruses. Thus, the L enzymatic domains exhibit common and virus-specific properties in cap formation among pneumoviruses and rhabdoviruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.